R. Weberg

1.2k total citations
36 papers, 971 citations indexed

About

R. Weberg is a scholar working on Surgery, Gastroenterology and Nutrition and Dietetics. According to data from OpenAlex, R. Weberg has authored 36 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 14 papers in Gastroenterology and 8 papers in Nutrition and Dietetics. Recurrent topics in R. Weberg's work include Helicobacter pylori-related gastroenterology studies (20 papers), Gastroesophageal reflux and treatments (9 papers) and Eosinophilic Esophagitis (9 papers). R. Weberg is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (20 papers), Gastroesophageal reflux and treatments (9 papers) and Eosinophilic Esophagitis (9 papers). R. Weberg collaborates with scholars based in Norway, Sweden and Denmark. R. Weberg's co-authors include Arnold Berstad, Björn Hoel, Martin Hauer‐Jensen, G Stene-Larsen, Øystein Bjørtuft, Helge Bell, N Raknerud, K. Try, Egil Haug and O. Lange and has published in prestigious journals such as Gastroenterology, Alimentary Pharmacology & Therapeutics and Analytical and Bioanalytical Chemistry.

In The Last Decade

R. Weberg

36 papers receiving 893 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Weberg Norway 16 636 455 137 115 111 36 971
Walid Aldoori United States 15 949 1.5× 102 0.2× 47 0.3× 28 0.2× 44 0.4× 27 1.4k
R Castelletto Argentina 11 525 0.8× 222 0.5× 7 0.1× 130 1.1× 134 1.2× 19 968
Fernando Maluenda Chile 19 1.0k 1.6× 244 0.5× 21 0.2× 345 3.0× 130 1.2× 34 1.9k
Ebru Uz Türkiye 16 182 0.3× 41 0.1× 41 0.3× 80 0.7× 243 2.2× 29 1.0k
MJ Stampfer United States 11 228 0.4× 27 0.1× 28 0.2× 125 1.1× 86 0.8× 11 1.5k
Karen Todd United States 7 154 0.2× 98 0.2× 11 0.1× 92 0.8× 73 0.7× 7 1.4k
Masashi Ishihara Japan 14 218 0.3× 87 0.2× 38 0.3× 126 1.1× 40 0.4× 53 744
Qianyi Wan China 16 110 0.2× 34 0.1× 93 0.7× 73 0.6× 98 0.9× 27 899
Linda Inman United States 6 139 0.2× 114 0.3× 43 0.3× 13 0.1× 50 0.5× 7 440
Philip R. Taylor United States 8 227 0.4× 25 0.1× 17 0.1× 162 1.4× 87 0.8× 10 834

Countries citing papers authored by R. Weberg

Since Specialization
Citations

This map shows the geographic impact of R. Weberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Weberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Weberg more than expected).

Fields of papers citing papers by R. Weberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Weberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Weberg. The network helps show where R. Weberg may publish in the future.

Co-authorship network of co-authors of R. Weberg

This figure shows the co-authorship network connecting the top 25 collaborators of R. Weberg. A scholar is included among the top collaborators of R. Weberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Weberg. R. Weberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bell, Helge, et al.. (1993). Serum Carbohydrate‐Deficient Transferrin as a Marker of Alcohol Consumption in Patients with Chronic Liver Diseases. Alcoholism Clinical and Experimental Research. 17(2). 246–252. 115 indexed citations
2.
Berstad, Arnold, et al.. (1992). Eosinophil Cationic Protein and Phospholipase A2Activity in Human Gastric Juice: With Emphasis on Helicobacter pylori Status and Effects of Antacids. Scandinavian Journal of Gastroenterology. 27(12). 1011–1017. 15 indexed citations
3.
Weberg, R., Arnold Berstad, & M. Osnes. (1992). Comparison of low-dose antacids, cimetidine, and placebo on 24-hour intragastric acidity in healthy volunteers. Digestive Diseases and Sciences. 37(12). 1810–1814. 6 indexed citations
4.
Weberg, R., et al.. (1992). Review: Is There a Place for Antacids in the Treatment of Helicobacter pylori Infection?. Scandinavian Journal of Gastroenterology. 27(12). 1006–1010. 2 indexed citations
5.
Aabakken, Lars, et al.. (1991). Gastrointestinal Bleeding: Dyspeptic Symptoms and Clinical Course in Relation to Use of Non-steroidal Antiinflammatory Drugs. Scandinavian Journal of Rheumatology. 20(5). 366–369. 8 indexed citations
6.
Aabakken, Lars, et al.. (1990). NSAID‐associated gastroduodenal damage: does famotidine protection extend into the mid‐and distal duodenum?. Alimentary Pharmacology & Therapeutics. 4(3). 295–303. 20 indexed citations
7.
Weberg, R., et al.. (1990). Acute effects of antacids on gastric juice components in duodenal ulcer patients. European Journal of Clinical Investigation. 20(5). 511–515. 12 indexed citations
8.
Weberg, R., et al.. (1990). Suppression of Gastric Urease Activity by Antacids. Scandinavian Journal of Gastroenterology. 25(5). 496–500. 9 indexed citations
9.
Weberg, R. & Arnold Berstad. (1989). Symptomatic Effect of a Low-Dose Antacid Regimen in Reflux Oesophagitis. Scandinavian Journal of Gastroenterology. 24(4). 401–406. 52 indexed citations
10.
Weberg, R., et al.. (1989). Acute damage of gastroduodenal mucosa by acetylsalicylic acid: no prolonged protection by antacids. Alimentary Pharmacology & Therapeutics. 3(6). 585–590. 2 indexed citations
11.
Weberg, R. & Arnold Berstad. (1988). Low-Dose Antacids and Pirenzepine in the Treatment of Patients with Non-Ulcer Dyspepsia and Erosive Prepyloric Changes: A Randomized, Double-Blind, Placebo-Controlled Trial. Scandinavian Journal of Gastroenterology. 23(2). 237–243. 24 indexed citations
12.
Weberg, R., J. H. Dybdahl, Per G. Farup, et al.. (1988). Low-Dose Antacids or Cimetidine for Duodenal Ulcer?. Gastroenterology. 95(6). 1465–1469. 22 indexed citations
13.
Stene-Larsen, G, et al.. (1988). Relationship of Overweight to Hiatus Hernia and Reflux Oesophagitis. Scandinavian Journal of Gastroenterology. 23(4). 427–432. 129 indexed citations
14.
Berstad, Arnold, Bruce Alexander, R. Weberg, et al.. (1988). Antacids Reduce Campylobacter pylori Colonization Without Healing the Gastritis in Patients With Nonulcer Dyspepsia and Erosive Prepyloric Changes. Gastroenterology. 95(3). 619–624. 39 indexed citations
15.
Vergin, H, et al.. (1987). Gastric Prostaglandin E2Release Induced by Aluminium Hydroxide and Aluminium Hydroxide-Containing Antacids in Rats: Effect of Low Doses and Citric Acid. Scandinavian Journal of Gastroenterology. 22(7). 884–888. 8 indexed citations
16.
Weberg, R., et al.. (1987). Urinary Excretion of Aluminium after Ingestion of Sucralfate and an Aluminium-Containing Antacid in Man. Scandinavian Journal of Gastroenterology. 22(5). 615–618. 30 indexed citations
17.
Weberg, R. & Arnold Berstad. (1986). Gastrointestinal absorption of aluminium from single doses of aluminium containing antacids in man. European Journal of Clinical Investigation. 16(5). 428–432. 89 indexed citations
18.
Berstad, Arnold, et al.. (1986). Relationship of Hiatus Hernia to Reflux Oesophagitis A Prospective Study of Coincidence, Using Endoscopy. Scandinavian Journal of Gastroenterology. 21(1). 55–58. 129 indexed citations
19.
Weberg, R., et al.. (1985). Duodenal Ulcer Healing with Four Antacid Tablets Daily. Scandinavian Journal of Gastroenterology. 20(9). 1041–1045. 50 indexed citations
20.
Weberg, R., Arnold Berstad, Jan Aaseth, & Jan A. Falch. (1985). Mineral-Metabolic Side Effects of Low-Dose Antacids. Scandinavian Journal of Gastroenterology. 20(6). 741–746. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Walid Aldoori Breakdown of academic impact, for papers by R Castelletto Breakdown of academic impact, for papers by Fernando Maluenda Breakdown of academic impact, for papers by Ebru Uz Breakdown of academic impact, for papers by MJ Stampfer Breakdown of academic impact, for papers by Karen Todd Breakdown of academic impact, for papers by Masashi Ishihara Breakdown of academic impact, for papers by Qianyi Wan Breakdown of academic impact, for papers by Linda Inman Breakdown of academic impact, for papers by Philip R. Taylor
Rankless by CCL
2026